Methamphetamine Abuse Treatment in Patients With AIDS - 1
NCT ID: NCT00000321
Last Updated: 2017-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
INTERVENTIONAL
1996-10-31
2001-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIV
NCT06538285
A Behavioral Trial for the Treatment of Methamphetamine Dependence. - 1
NCT00033124
Flupenthixol Decanoate in Methamphetamine Smoking - 1
NCT00000241
Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1
NCT00033072
Assessment of Interactions Between Methamphetamine and Aripiprazole - 1
NCT00089440
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
TREATMENT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Desipramine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Friends Research Institute, Inc.
OTHER
National Institute on Drug Abuse (NIDA)
NIH
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frank Gawin, M.D.
Role: PRINCIPAL_INVESTIGATOR
Friends Research Institute, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Friends Research Institute
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R01-10643-1
Identifier Type: -
Identifier Source: secondary_id
NIDA-10643-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.